Press Releases from Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH (1 total)
Early Targeting of Cystic Fibrosis
Hope of an early preventative therapy through a Germany-wide screening of newborns. - Cystic fibrosis or mucoviscidosis continues to be responsible for the most deaths caused by a hereditary disease in Europe and North America.
At the Heidelberg University Hospital, researchers have developed for the first time an effective preventative therapy for the disease in a mouse model using amiloride. By newborn screening for cystic fibrosis, it would be…
